This inventor holds 1 USPTO granted patent. Top assignees: Deutsches Krebsforschungszentrum, The J. David Gladstone Institutes. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 159 
1 out of 91 Years Active: 2009
Title: Alexander P. Doerr: Innovator in Immunogenic Compositions
Introduction
Alexander P. Doerr is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of immunology, particularly in the development of immunogenic compositions related to HIV-1.
Latest Patents
His most recent patent, titled "Immunogenic compositions comprising HIV-1 acetylated Tat polypeptides," focuses on compositions that include acetylated Tat protein of an immunodeficiency virus. This invention provides antibodies that specifically bind to an acetylated Tat polypeptide. Additionally, it outlines methods for inducing an immune response to the immunodeficiency virus Tat protein in individuals and methods for inhibiting transcriptional activation of the virus in cells.
Career Highlights
Throughout his career, Alexander P. Doerr has worked with prestigious institutions such as the J. David Gladstone Institutes and the Deutsches Krebsforschungszentrum. His work has been instrumental in advancing research in the field of immunology.
Collaborations
He has collaborated with notable colleagues, including Melanie Ott and Eric M. Verdin, contributing to various research projects and innovations.
Conclusion
Alexander P. Doerr's work in immunogenic compositions showcases his dedication to advancing medical science and improving health outcomes. His contributions are vital in the ongoing fight against immunodeficiency viruses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile